Recombinant Human MIS RII Fc Chimera Protein, CF 4749-MR-050 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human MIS RII Fc Chimera Protein, CF
CompanyR&D Systems, a Bio-Techne Brand
Price $576.00Supplier Page View Company Product Page
Catalog Number4749-MR-050
FormatLyophilized from a 0.2 µm filtered solution in PBS
SpeciesHuman
Size50 ug
Molecule NameMIS RII
NCBI Full Gene Nameanti-Mullerian hormone receptor type 2
NCBI Gene AliasesAMHR, MISRII, MISR2, MRII
Purity>90%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular WeightObserved: 60-65 kDa, reducing conditions
Theoretical: 40.2 kDa (monomer)
ApplicationsBinding Activity
Conjugate/TagUnconjugated
Source/Expression SystemNS0-derived Recombinant Human MIS RII Fc Chimera Protein, CF
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survivalInternational journal of oncologyJuly 1, 2021Chauvin M, Garambois V, Choblet S, Colombo PE, Chentouf M, Gros L, De Brauwere DP, Duonor-Cerutti M, Dumas K, Robert B, et al.no. 10227-H08B; Sino Biological, Inc.), ALK3 (cat. no. 10446-H08H; Sino Biological, Inc.) or AMHRII (4749-MR-050; R&D Systems, Inc.) used at 500 ng/ml. The plates were subsequently washed three times with PBS/0.01%

(2) Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growthThe Journal of biological chemistryAugust 26, 2011Castonguay R, Werner ED, Matthews RG, Presman E, Mulivor AW, Solban N, Sako D, Pearsall RS, Underwood KW, Seehra J, et al.

International journal of oncology